Duncan Gilmour
Analyst · Jaeson Schmidt with Lake Street Capital
Thank you, Nick. Starting on Slide 5. Revenue for the first quarter was $29.8 million, including $1.4 million from Alfamation, which was acquired with only 19 days or 2.5 weeks remaining in the quarter.
The $2.1 million decline compared with Q1 2023 was driven by a $2.7 million decline in semi, partially offset by growth in the Industrial and Defense/Aerospace markets.
Sequentially, first quarter revenue increased $1.9 million, with semi revenue up 39% off of the exceptionally low fourth quarter, while Defense/Aerospace was up 34%. Revenue from Alfamation was primarily in auto/EV, which helped offset a decline in that market within the organic businesses.
Moving to Slide 6. Gross margin of 43.8% for the quarter contracted 80 basis points sequentially, driven by a 100 basis point negative impact from the stub period for Alfamation. This is just a result of a timing mismatch on recognition of revenue and expenses given the short ownership time frame in Q1.
On a year-over-year comparison, gross margin contraction was a result of lower volume and product mix as well as the aforementioned impact from the acquisition. Our trailing 12 months gross profit of $55 million or 45.4% of sales is in line with our updated outlook for this year of gross margin between 44% and 46%.
As you can see on Slide 7, our operating expenses were up $1.1 million versus the prior year, driven by higher corporate development expenses, incremental operating expenses inherited with the acquisition and higher professional fees. As a percent of sales, OpEx increased 610 basis points to 42.2%.
Turning to Slide 8, you can see our bottom line and adjusted EBITDA results. For the quarter, net earnings were $662,000 or $0.05 per diluted share. Adjusted net earnings were $1.2 million or $0.10 per diluted share. Adjusted EPS reflects adding back tax-effected acquired intangible amortization. On an after-tax basis, our acquired intangible amortization amounted to approximately $500,000 or about $0.05 per diluted share in the first quarter. Adjusted EBITDA for Q1 was $1.8 million, representing a 6.1% adjusted EBITDA margin.
Slide 9 shows our capital structure and cash flow. We had a solid quarter of cash generation, adding $2.1 million from operations. Capital expenditures in the first quarter were $300,000, unchanged from the prior year period. Given our modest capital requirements to grow the organic business, free cash flow was $1.8 million. Cash equivalents at the end of the first quarter were $27.3 million, down $18 million from the trailing quarter, reflecting the use of approximately $19 million for the acquisition of Alfamation.
Borrowings increased in the quarter due to the $9 million in debt we assumed from the acquisition. We ended the quarter with total debt of $20.4 million, which we believe is very manageable and reflects a total debt leverage ratio of 1.6x. During the quarter, we repaid approximately $1 million of debt. We continue to have $30 million available with our delayed draw term loan and an incremental $10 million available under our revolver. As announced on Friday, we extended the maturity date on these facilities by 4-years to May 2031 and the drawdown period was extended 2-years to May 2026.
Turning to Slide 10 as we review our outlook for 2024. For the second quarter, we are expecting revenue to be between $34 million and $36 million, with gross margin of approximately 44% to 45%. Second quarter operating expenses, including amortization, are expected to be in the range of $14.5 million to $15 million. This range reflects the incremental operating costs gained from the acquisition of Alfamation and higher total intangible asset amortization. After tax, this is expected to be approximately $1.2 million or about $0.10 per share.
We are expecting EPS for the second quarter to be between breakeven to $0.06 per diluted share, while adjusted EPS should be approximately $0.10 to $0.16 per diluted share. As a reminder, we simply adjust for tax-effected amortization expense.
For our full year outlook, with the addition of Alfamation and the recent order trends Nick discussed, we now expect 2024 revenue to range from $140 million to $150 million. Gross margin for 2024 is expected to be approximately 44% to 46%, with expected operating expenses of roughly $56 million to $58 million. This includes tax adjusted intangible asset amortization expense of approximately $4.1 million. Our expected effective tax rate is now projected to be about 17% to 19%.
For capital expenditures in 2024, we expect to run between 1% to 2% of sales. As usual, our guidance does not include the potential impact from any non-operating expenses such as corporate development that may occur from time to time, nor does it include the potential impact from any additional acquisitions we may make. With that, if you will turn to Slide 11, I will now turn the call back over to Nick.